<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02641132</url>
  </required_header>
  <id_info>
    <org_study_id>0091-13-MMC</org_study_id>
    <nct_id>NCT02641132</nct_id>
  </id_info>
  <brief_title>Pterygium Head Body MMC1: Two Different Surgical Procedures and Their Effect on Endothelial Cell Count.</brief_title>
  <acronym>PHB-MMC1</acronym>
  <official_title>The Comparison of Endothelial Cell Count in Pterygium Surgery Relating to the Timing of MMC Application.</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Meir Medical Center</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Meir Medical Center</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      To evaluate changes in endothelial cell count after pterygium surgery with mitomycin C (MMC)
      0.02%
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      To evaluate the change in endothelial cell count in patients after pterygium surgery with
      mitomycin C (MMC) 0.02% for 2 minutes in 2 groups.

        -  The control group: application of MMC after excision of the body of the pterygium
           without the head

        -  The study group: application of MMC after excision of the body and the head of the
           pterygium
    </textblock>
  </detailed_description>
  <overall_status>Unknown status</overall_status>
  <last_known_status>Not yet recruiting</last_known_status>
  <start_date>September 2015</start_date>
  <completion_date type="Anticipated">December 2016</completion_date>
  <primary_completion_date type="Anticipated">December 2016</primary_completion_date>
  <phase>Phase 4</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Prevention</primary_purpose>
    <masking>Single (Participant)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Endothelial cell count</measure>
    <time_frame>3 months after surgery</time_frame>
  </primary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">62</enrollment>
  <condition>Pterygium</condition>
  <arm_group>
    <arm_group_label>Pterygium surgery: Head and body.</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Application of Mitomycin C 0.02% after excision of the body and the head of the pterygium.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Pterygium surgery: Body.</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Application of Mitomycin C 0.02% after excision of the body only of the pterygium.</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Mitomycin C 0.02%</intervention_name>
    <description>Pterygium excision with application of mitomycin C</description>
    <arm_group_label>Pterygium surgery: Head and body.</arm_group_label>
    <arm_group_label>Pterygium surgery: Body.</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>Pterygium surgery</intervention_name>
    <description>Two different procedures- excision of the head and the body and excision of the head only</description>
    <arm_group_label>Pterygium surgery: Head and body.</arm_group_label>
    <arm_group_label>Pterygium surgery: Body.</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Males/females &gt;18 Years old

          -  Pterygium with indication to operate

          -  Subjects that are able to sign an informed consent

        Exclusion Criteria:

          -  Recurrent Pterygium/suspected tumor lesion

          -  Patients with endothelial cell diseases

          -  Patients after anterior segment surgery

          -  Patients with low compliance

          -  Patients without judgment ability

          -  Pregnancy

          -  Patients participated in another survey
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_contact>
    <last_name>Fani Segev, MD</last_name>
    <phone>+792526995044</phone>
    <email>fsegev@netvision.net.il</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Leena Asalee, MD</last_name>
    <phone>+972543031396</phone>
    <email>leenaasalee@yahoo.com</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Meir medical centre</name>
      <address>
        <city>Kfar saba</city>
        <country>Israel</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Sackler school of medicine</name>
      <address>
        <city>Tel aviv</city>
        <country>Israel</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Israel</country>
  </location_countries>
  <reference>
    <citation>Avisar R, Avisar I, Bahar I, Weinberger D. Effect of mitomycin C in pterygium surgery on corneal endothelium. Cornea. 2008 Jun;27(5):559-61. doi: 10.1097/ICO.0b013e318165b158.</citation>
    <PMID>18520505</PMID>
  </reference>
  <reference>
    <citation>Bahar I, Kaiserman I, Lange AP, Slomovic A, Levinger E, Sansanayudh W, Slomovic AR. The effect of mitomycin C on corneal endothelium in pterygium surgery. Am J Ophthalmol. 2009 Mar;147(3):447-452.e1. doi: 10.1016/j.ajo.2008.08.035. Epub 2008 Nov 7.</citation>
    <PMID>18992871</PMID>
  </reference>
  <reference>
    <citation>Avisar R, Apel I, Avisar I, Weinberger D. Endothelial cell loss during pterygium surgery: importance of timing of mitomycin C application. Cornea. 2009 Sep;28(8):879-81. doi: 10.1097/ICO.0b013e3181a3900c.</citation>
    <PMID>19654528</PMID>
  </reference>
  <reference>
    <citation>Kheirkhah A, Izadi A, Kiarudi MY, Nazari R, Hashemian H, Behrouz MJ. Effects of mitomycin C on corneal endothelial cell counts in pterygium surgery: role of application location. Am J Ophthalmol. 2011 Mar;151(3):488-93. doi: 10.1016/j.ajo.2010.09.014. Epub 2011 Jan 13.</citation>
    <PMID>21236405</PMID>
  </reference>
  <verification_date>August 2015</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>December 23, 2015</study_first_submitted>
  <study_first_submitted_qc>December 23, 2015</study_first_submitted_qc>
  <study_first_posted type="Estimate">December 29, 2015</study_first_posted>
  <last_update_submitted>December 23, 2015</last_update_submitted>
  <last_update_submitted_qc>December 23, 2015</last_update_submitted_qc>
  <last_update_posted type="Estimate">December 29, 2015</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Meir Medical Center</investigator_affiliation>
    <investigator_full_name>segev fani</investigator_full_name>
    <investigator_title>Department of Ophthalmology, Meir medical centre, Kfar saba, Isreal</investigator_title>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Pterygium</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Mitomycins</mesh_term>
    <mesh_term>Mitomycin</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

